Skip to main content

Advertisement

SpringerLink
Log in

In vivo Engineering of Chromosome 19 q-arm by Employing the CRISPR/AsCpf1 and ddAsCpf1 Systems in Human Malignant Gliomas (Hypothesis)

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Deletions of the q13.3 region of chromosome 19 have been found commonly in all three main kinds of diffuse human malignant gliomas, powerfully demonstrating the existence of tumor suppressor genes in this region. Consistent with the previous studies, the most common deletion interval has been mapped to a roughly 4 Mb region of 19q13.3 between the APOC2 and HRC genes, between genetic markers D19S219 and D19S246. EML2 is a tumor suppressor gene that is located on 19q13.32 and is considerably methylated in high-grade gliomas. Notably, MIR330 gene that is situated within the non-coding intronic region of EML2 is also detected as an oncosuppressor-miR in a variety of cancers including gliomas. Additionally, glioma oncoprotein Bcl2L12 which is located on 19q13.33 is significantly overexpressed in glioblastoma multiform and has a pivotal role in cancer evolution and resistance to apoptosis. Other genes such as MIR519D and NOP53 are also discovered as tumor suppressor genes in gliomas which are located on 19q13.3 and 19q13.4, respectively. Therefore, we hypothesize that a CRISPR/AsCpf1-based genome engineering strategy might be utilized to attach these deleted sizeable chromosomal portions of genes coding tumor suppressors as vital parts of the chromosome 19 q-arm with the purpose of treatment of this chromosomal abnormality in gliomas. Also, we can concurrently employ the CRISPR-ddAsCpf1 strategy for the precise suppression of Bcl2L12 oncogene in glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Amfo K, Neyns B, Teugels E, Lissens W, Bourgain C, de Sutter P, Vandamme B, Vamos E, de Greve J (1995) Frequent deletion of chromosome 19 and a rare rearrangement of 19p13. 3 involving the insulin receptor gene in human ovarian cancer. Oncogene 11:351–358

    CAS  PubMed  Google Scholar 

  • Balaj L, Atai NA, Chen W, Mu D, Tannous BA, Breakefield XO, Skog J, Maguire CAJSR (2015) Heparin affinity purification of extracellular vesicles. 5:10266

    CAS  Google Scholar 

  • Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B (1997) Loss of heterozygosity in human ovarian cancer on chromosome 19q. Gynecologic oncology 66:36–40

    Article  CAS  PubMed  Google Scholar 

  • Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC ,Macdonald DR, Ino Y (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. JNCI: J Natl Cancer Inst 90:1473–1479

  • Chen J, Chen T, Zhu Y, Li Y, Zhang Y, Wang Y, Li X, Xie X, Wang J, Huang M (2019) circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. Journal of experimental & clinical cancer research 38:1–17

    Article  Google Scholar 

  • Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, Errami Y, Dong MB, Martinez MA, Zhang S (2017) AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nature neuroscience 20:1329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chu C, Liu X, Bai X, Zhao T, Wang M, Xu R, Li M, Hu Y, Li W, Yang L (2018a) MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3. Int J Biol Sci 14:228

  • Chu CW, Yang MC, Chou CH, Huang WS, Hsiao BX, Wang YT, Chiou SJ, Loh JK, Hong YR (2018) GSK3β-mediated Ser156 phosphorylation modulates a BH3-like domain in BCL2L12 during TMZ-induced apoptosis and autophagy in glioma cells. International journal of molecular medicine 42:905–918

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cui X, Sun Y, Shen M, Song K, Yin X, Di W, Duan Y (2018) Enhanced chemotherapeutic efficacy of paclitaxel nanoparticles co-delivered with microRNA-7 by inhibiting paclitaxel-induced EGFR/ERK pathway activation for ovarian cancer therapy. ACS Appl Mater Interfaces 10:7821–7831

  • Dehay B, Dalkara D, Dovero S, Li Q, Bezard E (2012) Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques. Scientific reports 2:253

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE (2014) Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation. Nat Biotechnol 32:1262

  • Dong D, Ren K, Qiu X, Zheng J, Guo M, Guan X, Liu H, Li N, Zhang B, Yang D (2016) The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532:522

    Article  CAS  PubMed  Google Scholar 

  • Dreos R, Ambrosini G, Périer RC, Bucher P (2014) The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools. Nucleic acids research 43:D92–D96

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Duong CV, Emes RD, Wessely F, Yacqub-Usman K, Clayton RN, Farrell WE (2012) Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas. Endocrine-related cancer 19:805–816

    Article  CAS  PubMed  Google Scholar 

  • Feng L,  Ma J, Ji H, Liu Y, Hu W (2017) miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5. Biosci Rep 37:BSR20170019

  • Fonfara I, Richter H, Bratovič M, le Rhun A, Charpentier E (2016) The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532:517

    Article  CAS  PubMed  Google Scholar 

  • Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683–2710

    Article  CAS  PubMed  Google Scholar 

  • Gao P, Yang H, Rajashankar KR, Huang Z, Patel DJ (2016) Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition. Cell Res 26:901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hartmann C, Johnk L, Kitange G, Wu Y, Ashworth LK, Jenkins RB, Louis DN (2002) Transcript map of the 3.7-Mb D19S112–D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res 62:4100–4108

    CAS  PubMed  Google Scholar 

  • Hartmann C, Johnk L, Kitange G, Wu Y, Ashworth LK, Jenkins RB, Louis DN (2002b) Transcript map of the 3.7-Mb D19S112–D19S246 candidate tumor suppressor region on the long arm of chromosome. Cancer Res19(62):4100–4108

  • Helleday T, Lo J, van Gent DC, Engelward BP (2007) DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA repair 6:923–935

    Article  CAS  PubMed  Google Scholar 

  • Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X,  Shalem O (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827

  • Hudry E, Martin C, Gandhi S, György B, Scheffer DI, Mu D, Merkel SF, Mingozzi F, Fitzpatrick Z, Dimant HJGT (2016) Exosome-associated AAV vector as a robust and convenient neuroscience tool. 23:380

    CAS  Google Scholar 

  • Iida A, Takino N, Miyauchi H, Shimazaki K, Muramatsu SI (2013) Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice. BioMed Res Int

  • Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839–845

    CAS  PubMed  Google Scholar 

  • Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard I, Moos T, Duroux M (2014) A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta Rev Cancer 1846:75–87

  • Josefa Bello M, Leone PE, Vaquero J, De Campos JM, Elena Kusak M, Sarasa JL, Pestaña A, Rey JA (1995) Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 64:207–210

    Article  Google Scholar 

  • Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, Wang A, Sylvester MD, Schmidt TL, Kaspar RL, Butte MJ (2015) Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proceedings of the National Academy of Sciences 112:E1433–E1442

    Article  CAS  Google Scholar 

  • Kim HK, Song M, Lee J, Menon AV, Jung S, Kang Y-M, Choi JW, Woo E, Koh HC, Nam J-W (2017) In vivo high-throughput profiling of CRISPR–Cpf1 activity. Nat Methods 14:153

    Article  CAS  PubMed  Google Scholar 

  • Kouri FM, Jensen SA, Stegh AH (2012) The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond. Sci World J

  • Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91–95

    Article  CAS  PubMed  Google Scholar 

  • Lee S, Ahn Y-M, Kim J-Y, Cho Y-E, Park J-H (2020) Downregulation of NOP53 ribosome biogenesis factor leads to abnormal nuclear division and chromosomal instability in human cervical cancer cells. Pathol Oncol Res 26:453–459

    Article  CAS  PubMed  Google Scholar 

  • Li B, Zhao W, Luo X, Zhang X, Li C, Zeng C, Dong Y (2017) Engineering CRISPR–Cpf1 crRNAs and mRNAs to maximize genome editing efficiency. Nat Biomed Eng 1:0066

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu H, Li C, Yang J, Sun Y, Zhang S, Yang J, Yang L, Wang Y, Jiao B (2018) Long noncoding RNA CASC9/miR-519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis. J Cell Mol Med 22:6338–6344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu L, Chen P, Wang M, Li X, Wang J, Yin M, Wang Y (2017) C2c1-sgRNA complex structure reveals RNA-guided DNA cleavage mechanism. Mol Cell 65:310–322

    Article  CAS  PubMed  Google Scholar 

  • Maguire CA, Gianni D, Meijer DH, Shaket LA, Wakimoto H, Rabkin SD, Gao G, Sena-Esteves M (2010) Directed evolution of adeno-associated virus for glioma cell transduction. J Neuro-Oncol 96:337–347

    Article  Google Scholar 

  • Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH (2015) An updated evolutionary classification of CRISPR–Cas systems. Nat Rev Microbiol 13:722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McLendon RE, Halperin EC (2003) Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98:1745–1748

    Article  PubMed  Google Scholar 

  • Meliani A, Boisgerault F, Fitzpatrick Z, Marmier S, Leborgne C, Collaud F, Sola MS, Charles S, Ronzitti G, Vignaud A (2017) Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Adv 1:2019–2031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mora J, Cheung N-KV, Chen L, Qin J, Gerald W (2001) Loss of heterozygosity at 19q13. 3 is associated with locally aggressive neuroblastoma. Clinical cancer research 7:1358–1361

    CAS  PubMed  Google Scholar 

  • Moreno-Mateos MA, Fernandez JP, Rouet R, Vejnar CE, Lane MA, Mis E, Khokha MK, Doudna JA, Giraldez AJ (2017) CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing. Nat Commun 8:2024

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Moreno-Mateos MA, Fernandez JP, Rouet R, Vejnar CE, Lane MA, Mis E, Khokha MK, Doudna JA, Giraldez AJ (2017b) CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing. Nat Commun 8:2024

  • Muangsub T, Samsuwan J, Tongyoo P, Kitkumthorn N, Mutirangura A (2014) Analysis of methylation microarray for tissue specific detection. Gene 553:31–41

    Article  CAS  PubMed  Google Scholar 

  • Mukherjee B (2013) Editorial (thematic issue:“Nanosize drug delivery system”). Curr Pharm Biotechnol 14:1221–1221

    Article  CAS  PubMed  Google Scholar 

  • Nagarajan RP, Costello JF (2009) Molecular epigenetics and genetics in neuro-oncology. Neurotherapeutics 6:436–446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakamura M, Yang F, Fujisawa H, Yonekawa Y, Kleihues P, Ohgaki H (2000) Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J Neuropathol Exp Neurol 59:539–543

    Article  CAS  PubMed  Google Scholar 

  • Nakamura M, Yang F, Fujisawa H, Yonekawa Y, Kleihues P, Ohgaki H (2000b) Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J Neuropathol Exp Neurol 59:539–543

  • Nishimasu H, Nureki O (2017) Structures and mechanisms of CRISPR RNA-guided effector nucleases. Curr Opin Struct Biol 43:68–78

    Article  CAS  PubMed  Google Scholar 

  • Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, di Patre P-L, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892–6899

    Article  CAS  PubMed  Google Scholar 

  • Okahara F, Itoh K, Nakagawara A, Murakami M, Kanaho Y, Maehama T (2006) Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3, 4, 5-trisphosphate signals and tumorigenic transformation. Mol Biol Cell 17:4888–4895

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park HM, Liu H, Wu J, Chong A, Mackley V, Fellmann C, Rao A, Jiang F, Chu H, Murthy N (2018) Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo. Nat Commun 9:3313

  • Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RBJ (1992) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. G Chromosomes & Cancer 5:348–356

  • Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rezaei O, Honarmand K, Nateghinia S, Taheri M, Ghafouri-Fard S (2020) miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets. Exp Mol Pathol 117

  • Rezaei O, Tamizkar KH, Sharifi G, Taheri M, Ghafouri-Fard S (2021) Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma. Front Oncol 10

  • Richards MW, O’Regan L, Roth D, Montgomery JM, Straube A, Fry AM, Bayliss R (2015) Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain. Biochem J 467:529–536

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg JE, Lisle DK, Burwick JA, Ueki K, Mohrenweiser H, Louis D (1996) Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 13:2483–2485

    CAS  PubMed  Google Scholar 

  • Rosenberg JE, Lisle DK, Burwick JA, Ueki K, Mohrenweiser H, Louis D (1996b) Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 13:2483–2485

  • Rubio MP, Correa KM, Ueki K, Mohrenweiser HW, Gusella JF, von Deimling A, Louis DN (1994) The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Cancer Res 54:4760–4763

  • Samsuwan J, Muangsub T, Yanatatsaneejit P, Mutirangura A, Kitkumthorn N (2018) Combined Bisulfite Restriction Analysis for brain tissue identification. Forensic Sci Int 286:42–45

    Article  CAS  PubMed  Google Scholar 

  • San Filippo J, Sung P, Klein H (2008) Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem. 77:229–257

    Article  CAS  PubMed  Google Scholar 

  • Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J (2016) MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 5:1917–1946

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K (2015) Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mole Cell 60:385–397

    Article  CAS  Google Scholar 

  • Smithx JS, Smith B,  Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel, D O'fallon J, Yates AJO (1999) Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. 18:4144

  • Smith JS, Perry A, Borell TJ, Lee HK, O’Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–636

    Article  CAS  PubMed  Google Scholar 

  • Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW (2000) A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 64:44–50

    Article  CAS  PubMed  Google Scholar 

  • Stegh AH, Brennan C, Mahoney JA, Forloney KL, Jenq HT, Luciano JP, Protopopov A, Chin L, Depinho RA( 2010) Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Proc Natl Acad Sci 24:2194–2204

  • Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A, Louis DN, Chin L, Depinho RA (2008) Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci 105:10703–10708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H, Park K, Hannon GJ, Yuan J, Louis DN 2007 Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma, Proc Natl Acad Sci 21:98–111

  • Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, Mörgelin M, Belting M (2013) Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 288:17713–17724

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, Sur M, Zhang F (2015) In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol 33:102

    Article  CAS  PubMed  Google Scholar 

  • Taghavi MS, Akbarzadeh A, Mahdian R, Azadmanesh K, Javadi G (2013) Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells. Vitro Cell Dev Biol-Anim 49:465–472

    Article  CAS  Google Scholar 

  • Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569

    Article  PubMed  CAS  Google Scholar 

  • Tóth E, Weinhardt N, Bencsura P, Huszár K, Kulcsár PI, Tálas A, Fodor E, Welker E (2016) Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells. Biol Direct 11:46

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggaini ML, Albani F, Baruzzi A, Pession (2014) Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol Oncol 8:417–430

    Article  CAS  PubMed  Google Scholar 

  • von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Faßbender F, Nagel J, Menon AG (1994) Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. Cancer Res 54:1397–1401

    Google Scholar 

  • von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD,  Seizinger BRJCR  (1992) Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. 52:4277–4279

  • von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN, Wiestler OD (1994) Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 57:676–680

    Article  Google Scholar 

  • von Deimling A, Nagel J, Bender B, Schramm D, Lenartz J,  Louis DN, Wiestler OD (1994c) Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 57:676–680

  • Waha A, Rodrigues FJ, Waha A, Meyer-Puttlitz B, Cavenee WK, Huang TH-M, Wiestler OD, Yan PS (2004) Methylation profiling identifies epigenetic markers for high-grade gliomas. Cancer Genomics-Proteomics 1:209–214

    CAS  PubMed  Google Scholar 

  • Yamano T, Nishimasu H, Zetsche B, Hirano H, Slaymaker IM, Li Y, Fedorova I, Nakane T, Makarova KS, Koonin EV (2016) Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165:949–962

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang M-C, Loh J-K, Li Y-Y, Huang W-S, Chou C-H, Cheng J-T, Wang Y-T, Lieu A-S, Howng S-L, Hong Y-R (2015) Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma. Int J Oncol 46:1304–1316

    Article  CAS  PubMed  Google Scholar 

  • Yong WH, Chou D, Ueki K, Harsh IV GR, von Deimling A, Gusella JF, Mohrenweiser HW, Louis DN (1995) Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112. J Neuropathol Exp Neurol 54:622–626

  • Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163:759–771

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P. Volz SE, Joung J, van der Oost J, Regev AJC (2015b) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. 163:759–771

  • Zhang XH, Tee LY, Wang XG, Huang QS, Yang SH (2015) Off-target effects in CRISPR/Cas9-mediated genome engineering. Mol Ther–Nucleic Acids 4

  • Zhang X, Wang J, Cheng Q, Zheng X, Zhao G, Wang J (2017) Multiplex gene regulation by CRISPR-ddCpf1. Cell Discov 3:17018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Z, Dombroski JA, King MR (2020) Engineering of exosomes to target cancer metastasis. Cell Mol Bioeng 13:1–16

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was financially supported by Grant Number 28150 from Medical School of Shahid Beheshti University of Medical Sciences.

Author information

Authors and Affiliations

  1. Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    Atefe Abak

  2. Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran

    Hamed Shoorei

  3. Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammad Taheri

  4. Department of Medical Genetics. Shahid, Beheshti University of Medical Sciences, Tehran, Iran

    Soudeh Ghafouri-Fard

Authors
  1. Atefe Abak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamed Shoorei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Taheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Soudeh Ghafouri-Fard
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MT and SGF wrote the manuscript and revised it. AB and HS analyzed the data. All authors approved the manuscript.

Availability of Data and Materials

The analyzed data sets generated during the study are available from the corresponding author on reasonable request.

Corresponding authors

Correspondence to Mohammad Taheri or Soudeh Ghafouri-Fard.

Ethics declarations

Ethics Approval and Consent to Participant

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Shahid Beheshti University of Medical Sciences. All methods were performed in accordance with the relevant guidelines and regulations.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abak, A., Shoorei, H., Taheri, M. et al. In vivo Engineering of Chromosome 19 q-arm by Employing the CRISPR/AsCpf1 and ddAsCpf1 Systems in Human Malignant Gliomas (Hypothesis). J Mol Neurosci 71, 1648–1663 (2021). https://doi.org/10.1007/s12031-021-01855-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-021-01855-1

Keywords

Search

Navigation